Improving production efficiency in accordance with stringent quality standards.

Our quality management is implemented all in all processes – from production, regulatory affairs, quality assurance and distribution, until the customers receive our products. By managing each and every product in accordance with stringent quality standards, we support safe and secure medical environment. At the same time we also pursue production efficiency.

Our aim is to provide prompt responses to a variety of needs at reasonable price.

Production System

From development to production, everything is handled in-house.

Production system

In order to deliver reliable products to the front lines of medical care, we have established an “in-house development system”, from product design, trial production, and commercial production, and “in-house production system”, in which everything from procurement / composition of raw materials to the final sterilization of the products is integrated. We have four factories in Japan and four overseas, and introduce a system for integrated management and efficient production management and timely product supply.

Regulatory Affairs and Quality Assurance

Strict quality management in accordance with domestic and international standards.

Regulatory Affairs and Quality Assurance

In addition to the Pharmaceutical and Medical Device Act and applicable laws and regulations in Japan, our management conforms to the Quality Systems Regulation (U. S. Food and Drug Administration), and Medical Device Directive CE Marking of European Union, etc. In 2005, we obtained ISO13485 certification, the international quality management standard for medical devices. Moreover we conduct post-marketing surveillance to see how our devices are being used by hospitals and patients as part of risk management.


Reliable and prompt delivery is a part of quality.


Responding to a customer’s order with same-day shipment is how we at JMS think “quality” should be in Japan. We have constructed a same-day shipping system with distribution points throughout Japan.

Furthermore, we have developed a risk management system and logistics system to avoid any trouble to patient’s treatment due to delivery delay.